Association of a gliotoxic activity with active multiple sclerosis in US patients

被引:0
|
作者
Pierig, R [1 ]
Belliveau, J [1 ]
Amouri, R [1 ]
Ménard, A [1 ]
Rieger, F [1 ]
机构
[1] Hop Kremlin Bicetre, INSERM, U488, Equipe Neuromodulat & Neuropathol, F-94276 Le Kremlin Bicetre, France
关键词
multiple sclerosis; cerebrospinal fluid; gliotoxic activity; astrocytes; apoptosis; Alamar blue assay;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We recently found that cerebrospinal fluid (CSF) from multiple sclerosis (MS) patients contains a gliotoxic activity which induces programmed cell death of astrocytes and oligodendrocytes and could be the main contributing factor to the massive glial cell death seen in MS active lesions. A previous clinical study aimed at evaluating the gliotoxicity of CSF from a cohort of MS patients from France indicated that MS patients with the actin e form of the disease do indeed present significant CSF gliotoxicity, To extend this observation, the effect of 141 CSFs from United States patients with different neurological diseases (including 71 MS) was tested on unmortalized astrocytes. A cell death assay showed that a gliotoxic activity is significantly present in the CSF from MS patients with the active forms. Thus. this gliotoxic activity may represent a critical pathogenic factor in the neuropathology of active MS by playing a role both in demyelinisation and alteration of the blood-brain barrier.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 50 条
  • [1] Detection of a gliotoxic activity in the cerebrospinal fluid from multiple sclerosis patients
    Ménard, A
    Pierig, R
    Pelletier, J
    Bensa, P
    Belliveau, J
    Mandrand, B
    Perron, H
    Rieger, F
    [J]. NEUROSCIENCE LETTERS, 1998, 245 (01) : 49 - 52
  • [2] A gliotoxic factor and multiple sclerosis
    Ménard, A
    Amouri, R
    Dobránsky, T
    Charriaut-Marlangue, C
    Pierig, R
    Cifuentes-Diaz, C
    Ghandour, S
    Belliveau, J
    Gascan, H
    Hentati, F
    Lyon-Caen, O
    Perron, H
    Rieger, F
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 154 (02) : 209 - 221
  • [3] A NEW GLIOTOXIC ACTIVITY AND ITS IMPLICATIONS FOR THE IMMUNOPATHOGENESIS OF MULTIPLE-SCLEROSIS
    AMOURI, R
    DOBRANSKY, T
    BENJELLOUN, N
    RIEGER, F
    [J]. NEUROPSYCHIATRIE, 1995, 9 (02): : 94 - 94
  • [4] INFLUENCE OF FILTRATION ON A NEW GLIOTOXIC ACTIVITY IN CEREBROSPINAL-FLUID FROM MULTIPLE-SCLEROSIS PATIENTS
    DOBRANSKY, T
    AMOURI, R
    WOLLINSKY, KH
    WESTARP, ME
    RIEGER, F
    [J]. NEUROPSYCHIATRIE, 1995, 9 (02): : 89 - 93
  • [5] Comorbidity in US patients with multiple sclerosis
    Edwards, Natalie C.
    Munsell, Michael
    Menzin, Joseph
    Phillips, Amy L.
    [J]. PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 97 - 102
  • [6] Retrovirus MSRV and gliotoxic factor: potential biological markers in multiple sclerosis
    Perron, H
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 1998, 56 (04) : 427 - 438
  • [7] Disability progression of active and nonactive primary and secondary progressive multiple sclerosis patients in the US
    Watson, C.
    Sadetsky, N.
    Thirumalai, D.
    Barlev, A.
    Grant, N.
    Jones, E.
    Bogdanovich, S.
    Kresa-Reahl, K.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 466 - 466
  • [8] Association of microchimerism and Multiple sclerosis patients
    Talebian, F
    Lotfi, J
    Amirzargar, AA
    Khosravi, F
    Ghaffari, SH
    Hooshmand, F
    Jangoki
    Nikbin, B
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S251 - S252
  • [9] Causes of death in US patients with multiple sclerosis
    Reshef, S.
    Golub, H.
    Goodin, D.
    Cutter, G.
    Kaufman, D.
    Pleimes, D.
    Corwin, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 308 - 309
  • [10] Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis
    Lizak, Nathaniel
    Malpas, Charles B.
    Sharmin, Sifat
    Havrdova, Eva Kubala
    Horakova, Dana
    Izquierdo, Guillermo
    Eichau, Sara
    Lugaresi, Alessandra
    Duquette, Pierre
    Girard, Marc
    Prat, Alexandre
    Larochelle, Catherine
    Trojano, Maria
    Grand'Maison, Francois
    Grammond, Pierre
    Sola, Patrizia
    Ferraro, Diana
    Hupperts, Raymond
    Bergamaschi, Roberto
    Boz, Cavit
    Van Pesch, Vincent
    Spitaleri, Daniele
    Terzi, Murat
    Kalincik, Tomas
    [J]. JAMA NEUROLOGY, 2020, 77 (11) : 1398 - 1407